The central government has set itself a tight deadline of July this year for completing a series of reforms in the civil aviation sector.
With the opening up of the US and Japanese markets, the Indian mango industry expects Australia and New Zealand, the only two countries which still ban the fruit, to lift import restrictions soon.
With India slowly but steadily morphing into a global pharmaceutical R&D hub, scientists have run into short supply.
The ministry of company affairs, now known as the ministry of corporate affairs, plans to set up an Indian Institute of Corporate Affairs. Apart from training officials, the institute will also work as a think-tank for the ministry.
The changes would be immediately effective in countries like Columbia, South Korea, Peru and Panama, where FTAs are in the final stages of approval.
In a landmark judgment likely to benefit Indian generic drug manufacturers in a big way, the US Supreme Court has ruled against patenting of products with slight modifications.
The contract research and manufacturing services may soon replace generic drugs manufacturing as the preferred business option for Indian pharmaceutical industry, if growing revenues from CRAMS business is any indication.
Ranbaxy Laboratories, the country's biggest drugmaker, is all set to focus its energies in developing and marketing niche products where price erosion is minimal
The pace of privatisation of the Indian healthcare segment is expected to be the fastest in the coming years.
Over 30 domestic pharmaceutical companies, including Ranbaxy, Cipla, Nicholas Piramal, Zydus Cadila and Torrent, face a possible ban on the sale of the generic version of Merck's pain management drug in the Indian market.
Data from the Central Information Commission, the apex body that hears complaints regarding denial of information under RTI, shows that corporate houses are increasingly using RTI to extract information from public authorities.
Pfizer's blockbuster drug Viagra (sildenafil citrate), hitherto approved for use in treatment of erectile dysfunction, may soon acquire a new identity as a "life saving drug" in treating pulmonary arterial hypertension in children.
The venue of the battle by Swiss multinational Novartis AG against the rejection of its patent application for blockbuster cancer drug Gleevac will now shift to the Patent Appellate Board's office.
To help students pursuing higher education, the government plans o set up a higher education finance corporation.
Despite specific sectors like power, ports, roads and employment falling short of their targets, the Tenth Five-Year Plan 2002-'07 Five-Year Plan has recorded impressive gains in telecom, railways, airport and poverty alleviation.
The 10th Five-Year Plan, which ended on March 31, has come close to achieving the growth targets set at the outset of the Plan by the Planning Commission.
Australia has joined the UK, USA and Canada in warning its citizens against using unapproved traditional medicines from India and China.
Hetero is the only Indian partner of multinational drug major Roche Scientific for the manufacture and supply of the latter's patented drug, Tamilflu in developing countries.
The Railway Board issued a notification a few months ago under which divisional regional managers of certain zones were given financial powers to levy a surcharge from passengers who insist on seeking reservation for lower berths.
Merck is all set to introduce three of its money-spinning drugs - Cosopt, Invanz and Pneuvax in India.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances